Le Lézard
Classified in: Business
Subject: STR

Canadian Investment Regulatory Organization Trade Resumption - MDNA


TORONTO, April 26, 2024 /CNW/ - Trading resumes in:

Company: Medicenna Therapeutics Corp.

TSX Symbol: MDNA

All Issues: Yes

Resumption (ET): 8:30 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 19:49
Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. ("Zevra" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 19:45
Relativity Acquisition Corp. (the "Company") today announced that, on April 30, 2024, the Company received a determination letter (the "Letter") from the Nasdaq Listing Qualifications staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq")...

at 19:43
Pomerantz LLP is investigating claims on behalf of investors of XPEL, Inc. ("XPEL" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 19:43
Pomerantz LLP announces that a class action lawsuit has been filed against Equinix, Inc. ("Equinix" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext....

at 19:43
Pomerantz LLP is investigating claims on behalf of investors of Wolfspeed, Inc. ("Wolfspeed" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....

at 19:43
Pomerantz LLP is investigating claims on behalf of investors of Remitly Global, Inc. ("Remitly" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980....



News published on and distributed by: